Cabaletta Bio, Inc.
Long

Nice Pattern Developing

140
Cabaletta Bio is an early stage biotech. Keep an eye on breakout of pattern.
Stock could have huge upside potential due to novel approach of using
CAR-T Cell technology for Auto-Immune disease where as most have used it just for
cancer drugs

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.